Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Verimatrix Positioned as Leader in the 2023 SPARK Matrix™ for In-App Protection Report by Quadrant Knowledge Solutions: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix Positioned as Leader in the 2023 SPARK Matrix™ for In-App Protection Report by Quadrant Knowledge Solutions


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it was named as a 2023 technology leader in

EQS-News: Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing
EQS-News: Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing
EQS-News: Abivax announces the start of the roadshow for its proposed global offering and proposed Nasdaq listing
Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain: https://mms.businesswire.com/media/20200113005579/en/767035/5/Median_strapline.jpg
Median Technologies’ Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 – 24, 2023, Madrid, Spain


Regulatory News:



Median Technologies (ALMDT:PA) announced today that the Company will be participating in the prestigious 2023 European Society for Medical Oncology (ESMO) Congress, set to take

ABIONYX Pharma RACERS Study in Sepsis Selected for Late-Breaking Clinical Results Poster Presentation at the American Society of Nephrology (ASN) 2023 Annual Meeting "Kidney Week": https://mms.businesswire.com/media/20210302005302/en/862456/5/ABIONYX_W.jpg
ABIONYX Pharma RACERS Study in Sepsis Selected for Late-Breaking Clinical Results Poster Presentation at the American Society of Nephrology (ASN) 2023 Annual Meeting "Kidney Week"


ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world's only recombinant

Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech pre-announces preliminary 9-month results and lowers forecast for 2023
ROCTOOL: ROCTOOL: HALF YEAR RESULTS 2023
ROCTOOL: ROCTOOL: HALF YEAR RESULTS 2023
ROCTOOL: ROCTOOL: HALF YEAR RESULTS 2023
GEVELOT S.A.: PRESS RELEASE HALF YEAR 2023 REPORT
GEVELOT S.A.: PRESS RELEASE HALF YEAR 2023 REPORT
GEVELOT S.A.: PRESS RELEASE HALF YEAR 2023 REPORT
Poxel Announces its Participation at Upcoming Investor Conferences: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces its Participation at Upcoming Investor Conferences


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

Carbios Demonstrates Superior Performance of Its Enzyme in World-Renowned Scientific Publication: https://mms.businesswire.com/media/20191202005614/en/743643/5/LOGO-CARBIOS_Q.jpg
Carbios Demonstrates Superior Performance of Its Enzyme in World-Renowned Scientific Publication


Regulatory News:



Carbios (Euronext Growth Paris: ALCRB), a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastics and textiles

PATRIMOINE ET COMMERCE: Q3 2023 RESULTS +6,1% IN GROSS RENTAL INCOME AT €37.4M
PATRIMOINE ET COMMERCE: Q3 2023 RESULTS +6,1% IN GROSS RENTAL INCOME AT €37.4M
PATRIMOINE ET COMMERCE: Q3 2023 RESULTS +6,1% IN GROSS RENTAL INCOME AT €37.4M
Marlink Signs Multi-Year Agreement on EUTELSAT 10B for Maritime Connectivity Over EMEA: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
Marlink Signs Multi-Year Agreement on EUTELSAT 10B for Maritime Connectivity Over EMEA


Regulatory News:



Eutelsat Communications (Euronext Paris, London Stock Exchange; ETL) announces that Marlink has signed a multi-year multi-million commitment for GEO High Throughput Ku-band

Transgene and BioInvent - First Patient Treated in Part B of Phase I Trial Assessing the Novel Oncolytic Virus BT-001 in Combination With KEYTRUDA® (pembrolizumab): https://mms.businesswire.com/media/20191209005543/en/255636/5/logo_TRANSGENE.jpg
Transgene and BioInvent - First Patient Treated in Part B of Phase I Trial Assessing the Novel Oncolytic Virus BT-001 in Combination With KEYTRUDA® (pembrolizumab)


Regulatory News:



Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq

Verimatrix XTD wird bei den 7. Annual CyberSecurity Breakthrough Awards als Anwendungssicherheitslösung des Jahres ausgezeichnet: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD wird bei den 7. Annual CyberSecurity Breakthrough Awards als Anwendungssicherheitslösung des Jahres ausgezeichnet


Verimatrix, (Euronext Paris: VMX), der führende Anbieter von Sicherheit für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen bei den 7. Annual CyberSecurity Breakthrough Awards

EUTELSAT 117 West A selected by TV Azteca for its video distribution over Mexico: https://mms.businesswire.com/media/20191112005524/en/397236/5/Eutelsat_Communications_logo.jpg
EUTELSAT 117 West A selected by TV Azteca for its video distribution over Mexico


Regulatory News:



TV Azteca, a subsidiary of Mexico’s leading telecom operator, financial services, insurance, and retirement fund Grupo Salinas, has renewed its satellite capacity commitment

Verimatrix XTD Named Application Security Solution Of The Year in 7th Annual CyberSecurity Breakthrough Awards: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix XTD Named Application Security Solution Of The Year in 7th Annual CyberSecurity Breakthrough Awards


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it has been selected as winner of the

BILENDI: Resilient first-half results for 2023
BILENDI: Resilient first-half results for 2023
BILENDI: Resilient first-half results for 2023
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO  THE NUMBER OF SHARES AND VOTING RIGHTS  MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Verimatrix präsentiert Cybersicherheitslösungen auf der GovWare 2023: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix präsentiert Cybersicherheitslösungen auf der GovWare 2023


Verimatrix (Euronext Paris: VMX), der Marktführer bei der Bereitstellung menschenzentrierter Sicherheit für die moderne vernetzte Welt, gab heute bekannt, dass das Unternehmen seine Extended Threat

ServiceNow Announces Teleperformance as New AI Lighthouse Member: https://mms.businesswire.com/media/20191104005672/en/676465/5/logo_-_new.jpg
ServiceNow Announces Teleperformance as New AI Lighthouse Member


ServiceNow today announced that global digital services leader Teleperformance is joining the AI Lighthouse program. Teleperformance will collaborate on the design, development, and deployment of

Verimatrix To Showcase Cybersecurity Solutions at GovWare 2023: https://mms.businesswire.com/media/20200603005395/en/795668/5/VMX+logo+4210606c.jpg
Verimatrix To Showcase Cybersecurity Solutions at GovWare 2023


Regulatory News:



Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced it will highlight its Extended Threat Defense

Poxel Announces its Participation at Upcoming Scientific Conference: https://mms.businesswire.com/media/20210929005940/en/578635/5/POXEL_LOGO_Q.jpg
Poxel Announces its Participation at Upcoming Scientific Conference


Regulatory News:



POXEL SA (Euronext: POXEL - FR0012432516) (Paris:POXEL), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic

BILENDI: Bilendi awarded by the Market Research Society for its  worldwide research project with Harvard and Zurich  Universities
BILENDI: Bilendi awarded by the Market Research Society for its worldwide research project with Harvard and Zurich Universities
BILENDI: Bilendi awarded by the Market Research Society for its worldwide research project with Harvard and Zurich Universities
Kaufman & Broad SA: RESULTS FOR THE FIRST NINE MONTHS OF THE FINANCIAL YEAR 2023
Kaufman & Broad SA: RESULTS FOR THE FIRST NINE MONTHS OF THE FINANCIAL YEAR 2023
Kaufman & Broad SA: RESULTS FOR THE FIRST NINE MONTHS OF THE FINANCIAL YEAR 2023
EQS-News: Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
EQS-News: Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
EQS-News: Abivax highlights obefazimod ulcerative colitis program with new data to be presented at the UEG Week 2023
EQS-News: Abivax files registration statement for proposed initial public offering in the United States
EQS-News: Abivax files registration statement for proposed initial public offering in the United States
EQS-News: Abivax files registration statement for proposed initial public offering in the United States